Cara Care receives seven million US dollars

The start-up now wants to expand to France. It is also getting a managing director.

The Berlin-based start-up Cara Care has raised seven million US dollars in a financing round. The main investor is the international food and nutrition manufacturer Dr. Schär AG. Previous investors include Sabadell Asabys and Johnson & Johnson Innovation.

Cara Care provides digital therapies for digestive health. The startup was recently approved by the German Federal Institute for Drugs and Medical Devices as a prescribable digital therapeutic app (DiGA). This means that the costs of the therapy can be covered by health insurers.

The start-up now wants to accelerate its sales in the U.S. as well as expand into France and other European markets. It also wants to expand its portfolio of digital therapeutics.

In addition, a new CEO, James (Jim) Mapes, is joining the company. The experienced healthcare executive is expected to work with founders Jesaja Brinkmann and Andre Sommer, as well as Chief Operating Officer Felix Köhler, to expand the startup's platform. "We are thrilled to have Jim at the helm of our team," says Brinkmann.